The Association of Thyroid Nodules with Metabolic Status: A Cross-Sectional SPECT-China Study

Table 2

Prevalence of TN and US characteristics (%) according to the status of metabolic diseases.

	Men			Women
	TN	Microcalcification	Taller-than-wide shape	TN	Microcalcification	Taller-than-wide shape
Met-S	48.2	2.3	1.5	67.6	1.0	3.3
Without Met-S	39.6	1.0	1.9	52.3	0.9	2.1
value	<0.001	0.073	0.596	<0.001	0.731	0.102
Obesity	46.9	1.1	2.8	66.0	0.8	4.1
Without obesity	40.2	1.4	1.8	55.0	1.0	2.2
value	0.001	0.646	0.222	<0.001	0.696	0.007
Central obesity	47.1	1.6	2.5	65.0	1.2	3.4
Without central obesity	39.0	1.2	1.6	50.2	0.7	1.6
value	<0.001	0.498	0.207	<0.001	0.210	0.003
Diabetes	50.3	0.8	1.6	69.5	1.5	3.9
Without diabetes	39.7	1.5	2.1	54.7	0.9	2.2
value	<0.001	0.371	0.550	<0.001	0.318	0.086
Hyperlipidaemia	45.3	1.7	2.5	64.7	1.2	2.5
Without hyperlipidaemia	38.3	1.0	1.6	52.5	0.9	2.5
value	<0.001	0.276	0.168	<0.001	0.361	0.733
Hypertension	45.8	1.3	1.9	66.1	1.3	2.6
Without hypertension	36.3	1.4	2.3	49.6	0.8	2.4
value	<0.001	0.806	0.576	<0.001	0.168	0.572
NAFLD	44.8	1.3	2.0	63.5	1.5	3.8
Without NAFLD	38.3	1.0	2.3	54.0	0.8	2.0
value	<0.001	0.650	0.699	<0.001	0.084	0.008

Met-S: metabolic syndrome; NAFLD: nonalcoholic fatty liver disease.